Sökresultat - Mann, Johannes

Correspondence (letter to the editor): An Experimental Procedure Paid for by the General Public av Mann, Johannes, Hilgers, Karl, Veelken, Roland, Luft, Friedrich

Hämta fulltext Hämta fulltext Hämta fulltext

Phosphate Additives in Food—a Health Risk av Ritz, Eberhard, Hahn, Kai, Ketteler, Markus, Kuhlmann, Martin K, Mann, Johannes

Hämta fulltext Hämta fulltext Hämta fulltext

Multiglandular Hormone Deficiency in a Patient with Systemic Capillary Leak Syndrome av Then, Cornelia, Ritzel, Katrin, Seibold, Christa, Mann, Johannes F. E., Reincke, Martin

Hämta fulltext Hämta fulltext Hämta fulltext

Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo contro... av Marre, Michel, Lievre, Michel, Chatellier, Gilles, Mann, Johannes F E, Passa, Philippe, Ménard, Joël

Hämta fulltext Hämta fulltext Hämta fulltext

Predictors of Congestive Heart Failure after Treatment with an Endothelin Receptor Antagonist av Hoekman, Jamo, Lambers Heerspink, Hiddo J., Viberti, Giancarlo, Green, Damien, Mann, Johannes F.E., de Zeeuw, Dick

Hämta fulltext Hämta fulltext Hämta fulltext

Avosentan for Overt Diabetic Nephropathy av Mann, Johannes F.E., Green, Damian, Jamerson, Kenneth, Ruilope, Luis M., Kuranoff, Susan J., Littke, Thomas, Viberti, Giancarlo

Hämta fulltext Hämta fulltext Hämta fulltext

Blood HER2 and Uromodulin as Causal Mediators of CKD av Sjaarda, Jennifer, Gerstein, Hertzel C., Yusuf, Salim, Treleaven, Darin, Walsh, Michael, Mann, Johannes F.E., Hess, Sibylle, Paré, Guillaume

Hämta fulltext Hämta fulltext Hämta fulltext

Multiple sclerosis–like lesions and type I interferon signature in a patient with RVCL av Schuh, Elisabeth, Ertl-Wagner, Birgit, Lohse, Peter, Wolf, Waltraud, Mann, Johannes F., Lee-Kirsch, Min Ae, Hohlfeld, Reinhard, Kümpfel, Tania

Hämta fulltext Hämta fulltext Hämta fulltext

Prediction of the Effects of Liraglutide on Kidney and Cardiovascular Outcomes Based on Short-Term Changes in Multiple Risk Markers av Tye, Sok Cin, de Vries, Sieta T., Mann, Johannes F. E., Schechter, Meir, Mosenzon, Ofri, Denig, Petra, Heerspink, Hiddo J. L.

Hämta fulltext Hämta fulltext Hämta fulltext

Albuminuria and Rapid Loss of GFR and Risk of New Hip and Pelvic Fractures av Barzilay, Joshua I., Gao, Peggy, Clase, Catherine M., Mente, Andrew, Mann, Johannes F.E., Sleight, Peter, Yusuf, Salim, Teo, Koon K.

Hämta fulltext Hämta fulltext Hämta fulltext

Long-term treatment with biosimilar epoetin-α (HX575) in hemodialysis patients with renal anemia: real-world effectiveness and safety in the MONITOR-CKD5 study av London, Gérard, Mann, Johannes, Goldsmith, David, Combe, Christian, Dellanna, Frank , Zaoui, Philippe, Hoebel, Nadja, Krendyukov, Andriy, MacDonald, Karen, Abraham, Ivo

Hämta fulltext Hämta fulltext Hämta fulltext

Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease: Results From the LEADER Trial av Mann, Johannes F. E., Fonseca, Vivian, Mosenzon, Ofri, Raz, Itamar, Goldman, Bryan, Idorn, Thomas, von Scholten, Bernt Johan, Poulter, Neil R.

Hämta fulltext Hämta fulltext Hämta fulltext

Potential life-years gained over a 5-year period by correcting DOPPS-identified modifiable practices in haemodialysis: results from the European MONITOR-CKD5 study av Combe, Christian, Mann, Johannes, Goldsmith, David, Dellanna, Frank, Zaoui, Philippe, London, Gérard, Denhaerynck, Kris, Krendyukov, Andriy, Abraham, Ivo, MacDonald, Karen

Hämta fulltext Hämta fulltext Hämta fulltext

A Gene Variant in CERS2 Is Associated with Rate of Increase in Albuminuria in Patients with Diabetes from ONTARGET and TRANSCEND av Shiffman, Dov, Pare, Guillaume, Oberbauer, Rainer, Louie, Judy Z., Rowland, Charles M., Devlin, James J., Mann, Johannes F., McQueen, Matthew J.

Hämta fulltext Hämta fulltext Hämta fulltext

Health‐related quality of life in people with type 2 diabetes participating in the LEADER trial av Nauck, Michael A., Buse, John B., Mann, Johannes F. E., Pocock, Stuart, Bosch‐Traberg, Heidrun, Frimer‐Larsen, Helle, Ye, Qing, Gray, Alastair

Hämta fulltext Hämta fulltext Hämta fulltext

Safety of Liraglutide in Type 2 Diabetes and Chronic Kidney Disease av Mann, Johannes F.E., Fonseca, Vivian A., Poulter, Neil R., Raz, Itamar, Idorn, Thomas, Rasmussen, Søren, von Scholten, Bernt Johan, Mosenzon, Ofri

Hämta fulltext Hämta fulltext Hämta fulltext

Changes in Albuminuria Predict Mortality and Morbidity in Patients with Vascular Disease av Schmieder, Roland E., Mann, Johannes F. E., Schumacher, Helmut, Gao, Peggy, Mancia, Giuseppe, Weber, Michael A., McQueen, Matthew, Koon, Teo, Yusuf, Salim

Hämta fulltext Hämta fulltext Hämta fulltext

Potential kidney protection with liraglutide and semaglutide: Exploratory mediation analysis av Mann, Johannes F. E., Buse, John B., Idorn, Thomas, Leiter, Lawrence A., Pratley, Richard E., Rasmussen, Søren, Vilsbøll, Tina, Wolthers, Benjamin, Perkovic, Vlado

Hämta fulltext Hämta fulltext Hämta fulltext

Effects of ACE inhibitors and angiotensin receptor blockers: protocol for a UK cohort study using routinely collected electronic health records with validation against the ONTARGET... av Baptiste, Paris J, Wong, Angel Y S, Schultze, Anna, Cunnington, Marianne, Mann, Johannes F E, Clase, Catherine, Leyrat, Clémence, Tomlinson, Laurie A, Wing, Kevin

Hämta fulltext Hämta fulltext Hämta fulltext

Risk Prediction for Early CKD in Type 2 Diabetes av Dunkler, Daniela, Gao, Peggy, Lee, Shun Fu, Heinze, Georg, Clase, Catherine M., Tobe, Sheldon, Teo, Koon K., Gerstein, Hertzel, Mann, Johannes F.E., Oberbauer, Rainer

Hämta fulltext Hämta fulltext Hämta fulltext